ZA962271B - Peroral controlled release composition - Google Patents

Peroral controlled release composition

Info

Publication number
ZA962271B
ZA962271B ZA962271A ZA962271A ZA962271B ZA 962271 B ZA962271 B ZA 962271B ZA 962271 A ZA962271 A ZA 962271A ZA 962271 A ZA962271 A ZA 962271A ZA 962271 B ZA962271 B ZA 962271B
Authority
ZA
South Africa
Prior art keywords
composition
drug
pct
controlling agent
peroral
Prior art date
Application number
ZA962271A
Other languages
English (en)
Inventor
Martti Marvola
Esko Marttila
Reija Yrjola
Esa Lahdenpaa
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of ZA962271B publication Critical patent/ZA962271B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA962271A 1995-03-21 1996-03-20 Peroral controlled release composition ZA962271B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI951316A FI98343C (fi) 1995-03-21 1995-03-21 Peroraalinen formulaatio

Publications (1)

Publication Number Publication Date
ZA962271B true ZA962271B (en) 1996-09-30

Family

ID=8543092

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA962271A ZA962271B (en) 1995-03-21 1996-03-20 Peroral controlled release composition

Country Status (16)

Country Link
US (1) US5962024A (no)
EP (1) EP0817615B1 (no)
JP (1) JPH11502217A (no)
AT (1) ATE221771T1 (no)
AU (1) AU694849B2 (no)
CA (1) CA2213747A1 (no)
DE (1) DE69622850T2 (no)
DK (1) DK0817615T3 (no)
ES (1) ES2181874T3 (no)
FI (1) FI98343C (no)
IL (1) IL117582A (no)
NO (1) NO312705B1 (no)
NZ (1) NZ303683A (no)
PT (1) PT817615E (no)
WO (1) WO1996029058A1 (no)
ZA (1) ZA962271B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998024412A2 (en) * 1996-12-05 1998-06-11 The Board Of Trustees Of The University Of Illinois Compounds useful against diseases of the colon and methods for orally administering same
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US6110500A (en) * 1998-03-25 2000-08-29 Temple University Coated tablet with long term parabolic and zero-order release kinetics
ES2339003T3 (es) * 2002-08-29 2010-05-14 Activbiotics Pharma Llc Rifalazil para tratar infecciones por clostridium difficile.
US20050025829A1 (en) * 2003-07-29 2005-02-03 Kim Cherng-Ju Controlled drug release tablets
JP4771956B2 (ja) 2003-11-04 2011-09-14 スパーナス ファーマシューティカルズ インコーポレイテッド バイオアベイラビリティーエンハンサを含む第四級アンモニウム化合物の組成物
US7410978B2 (en) * 2003-11-04 2008-08-12 Supernus Pharmaceuticals, Inc. Once daily dosage forms of trospium
US8481565B2 (en) 2004-12-27 2013-07-09 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
US20060159753A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Matrix type sustained-release preparation containing basic drug or salt thereof
US10071060B2 (en) * 2005-07-08 2018-09-11 Bioventures, Llc Asymmetrically coated table
US8357394B2 (en) * 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US20080139526A1 (en) * 2006-12-06 2008-06-12 Donald Treacy Modified release dosage forms of amoxicillin
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US7713549B2 (en) * 2006-06-30 2010-05-11 Board Of Trustees Of The University Of Arkansas Extended release perforated tablet
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
NZ592049A (en) 2008-10-03 2012-11-30 Falk Pharma Gmbh Compositions and methods for the treatment of bowel diseases with granulated mesalamine
WO2010061846A1 (ja) * 2008-11-25 2010-06-03 田辺三菱製薬株式会社 口腔内速崩壊性錠及びその製造方法
JP6203816B2 (ja) 2012-03-29 2017-09-27 セラバイオーム，エルエルシー 回腸及び虫垂に対して活性の胃腸部位特異的経口ワクチン接種製剤
US9907755B2 (en) 2013-03-14 2018-03-06 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
CA3077514C (en) * 2017-10-25 2022-10-11 Chiesi Farmaceutici S.P.A. Delayed release deferiprone tablets and methods of using the same
IT201800011120A1 (it) * 2018-12-14 2020-06-14 Dpl Pharma S P A Composizioni farmaceutiche orali solide per la somministrazione di mesalazina o suoi derivati

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9002337D0 (en) * 1990-02-02 1990-04-04 Orion Yhtymae Oy Compounds useful in treating inflammatory bowel disease
PT93637A (pt) * 1989-04-20 1990-11-20 Procter & Gamble Metodo para o tratamento de desordens funcionais intestinais/colonicas, especialmente o sindrome de irritacao intestinal
JPH0334928A (ja) * 1989-06-29 1991-02-14 Teikoku Seiyaku Kk 潰瘍性大腸炎およびクローン病治療用経口投与製剤
US5209933A (en) * 1990-01-10 1993-05-11 Syntex (U.S.A.) Inc. Long acting calcium channel blocker composition
WO1992016214A1 (en) * 1991-03-15 1992-10-01 Norwich Eaton Pharmaceuticals Inc. The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d)
SE501389C2 (sv) * 1992-04-24 1995-01-30 Leiras Oy Farmaceutiskt preparat och förfarande för dess framställning

Also Published As

Publication number Publication date
NO973950L (no) 1997-08-27
DK0817615T3 (da) 2002-11-25
WO1996029058A1 (en) 1996-09-26
FI98343C (fi) 1997-06-10
FI98343B (fi) 1997-02-28
JPH11502217A (ja) 1999-02-23
IL117582A (en) 2000-02-29
NZ303683A (en) 1998-07-28
PT817615E (pt) 2002-12-31
EP0817615A2 (en) 1998-01-14
IL117582A0 (en) 1996-07-23
DE69622850D1 (de) 2002-09-12
ES2181874T3 (es) 2003-03-01
CA2213747A1 (en) 1996-09-26
NO312705B1 (no) 2002-06-24
NO973950D0 (no) 1997-08-27
AU694849B2 (en) 1998-07-30
FI951316A (fi) 1996-09-22
AU5006196A (en) 1996-10-08
ATE221771T1 (de) 2002-08-15
US5962024A (en) 1999-10-05
EP0817615B1 (en) 2002-08-07
DE69622850T2 (de) 2003-04-24
FI951316A0 (fi) 1995-03-21

Similar Documents

Publication Publication Date Title
ZA962271B (en) Peroral controlled release composition
DE69630375D1 (de) Pharmazeutische dosierungsform zur freisetzung im colon
DE69619668D1 (de) Pharmazeutische dosisform mit mehrfacher darmlöslicher polymerbeschichtung zur wirkstoffabgabe im kolon
CA2268868A1 (en) Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
CA2268175A1 (en) Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
NZ511448A (en) A dosage form of diltiazem that exhibits a release rate profile corresponding to a "two peak" plasma level profile in vivo
MX9605646A (es) Preparacion de nifedipino de liberacion prolongada.
NZ260365A (en) Controlled release drug delivery device; solid core, delay coating, semi-permeable membrane, outer enteric coating
ID17428A (id) Sediaan farmasi da;lam bentuk kapsult bersalut yang dapat dilepas pada bagian bawah saluran pencernaan
AU5363196A (en) Diltiazem controlled release formulation
CA2383220A1 (en) Controlled release pellet formulation
EP1736144A3 (en) Orally disintegrable tablets
DE69636724D1 (de) Drei verschiedene polymertypen enthaltende formulierung mit verzögerter freigabe
HU9301577D0 (en) Method for manufacturing peroral medical preparative
BR9806174A (pt) Péletes tendo um núcleo revestido com um antifúngico e um polìmero
WO2002024174A3 (en) Sustained release composition containing clarithromycin
ATE291901T1 (de) Neue omeprazole und (s)-omeprazole zusammensetzung
PL307262A1 (en) Controllable release morphine preparation
ATE235232T1 (de) Lutschtablette zur modifizierten freisetzung von wirkstoffen im gastrointestinaltrakt
HU9301499D0 (en) Preparatives of controlled releasing of active agents
WO1996029058B1 (en) Peroral composition for controlled release in the lower gastrointestinal tract
CA2271569A1 (en) Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
CA2271560A1 (en) Pharmaceutical dosage form for colonic delivery
CA2187741A1 (en) Colon-specific drug release system
TH22631A (th) ลูกกลมแบบใหม่สำหรับควบคุมการปล่อยสารและการเตรียมยาที่ประกอบด้วยลูกกลมชนิดเดียวกัน